Medicare Part A and B premiums are set to increase by $9.80 next year; 20 experts from various specialties and institutions have developed updated brain death guidelines; many Black patients are strongly affected by multiple COVID-19 infections due to a lack of health insurance and health care access.
Medicare Part A and B Premiums Set to Rise Next Year
CMS announced Thursday that monthly Medicare Part A and B premiums are set to increase by 6% in 2024, according to The Hill. The premiums would increase by $9.80, meaning they would rise from $164.90 to $174.70. CMS explained that the Medicare Part B premium increase was mainly caused by projected increases in health care spending and meant as a partial remedy to the 340B-acquired drug payment policy for the 2018-2022 period under the Hospital Outpatient Prospective Payment System. The annual deductible for Medicare Part B beneficiaries will also go up ,from $226 to $240. This announcement is in line with what the Medicare Board of Trustees estimated the 2024 premium to be earlier this year.
Brain Death Guidelines Updated for First Time in More Than 10 Years
The American Academy of Neurology published updated guidelines on Wednesday to outline brain death in adult and pediatric patients for the first time in over a decade, according to Becker’s Hospital Review. Twenty experts from various specialties and institutions developed the updated guidelines, which included a 3-page checklist to use in evaluations. Like previous guidelines, the experts determined that brain death should be declared when a patient with a known catastrophic brain injury has permanent brain function loss. The guidelines also clarified questions, including those about apnea tests and neurological examinations, and noted that clinicians do not need consent to perform a brain death evaluation unless institution policy or state laws say otherwise.
Multiple COVID-19 Infections Could Devastate Black Communities
Doctors advise Black patients to be vigilant to avoid multiple COVID-19 infections, as the effects of the virus, when left unchecked, could devastate Black communities, according to NBC News. COVID-19 has a disproportionate impact on Black patients because they have more comorbidities, like heart disease, obesity, and diabetes. Piedmont Healthcare’s Jayne Morgan, MD, a cardiologist, explained that the virus strongly affects Black people because they often live in areas where quality health care is not easily available, and many do not have health insurance, creating a cycle of hardships that could stunt family growth. Protective measures to avoid multiple infections are encouraged, such as wearing a mask in crowded places, getting the vaccine and booster shots, engaging in consistent physical activity, and taking vitamins and minerals.
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More
Despite Record ACA Enrollment, Report Reveals Underinsured Americans are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access and affordability to health care.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More
2 Commerce Drive
Cranbury, NJ 08512